Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Maria I. Edilova, Jaclyn C. Law, Safoura Zangiabadi, Kenneth Ting, Achire N. Mbanwi, Andrea Arruda, David Uehling, Methvin Isaac, Michael Prakesch, Rima Al-awar, Mark D. Minden, Ali A. Abdul-Sater & Tania H. Watts. (2021) The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia. OncoImmunology 10:1.
Read now
Read now
Articles from other publishers (15)
Kallesh D. Jayappa, Brian Tran, Vicki L. Gordon, Christopher Morris, Shekhar Saha, Caroline C. Farrington, Caitlin M. O’Connor, Kaitlin P. Zawacki, Krista M. Isaac, Mark Kester, Timothy P. Bender, Michael E. Williams, Craig A. Portell, Michael J. Weber & Goutham Narla. (2023) PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis. Journal of Clinical Investigation 133:13.
Crossref
Crossref
Matthew Holmes, Gina B. Scott, Samuel Heaton, Tyler Barr, Basem Askar, Louise M.E. Müller, Victoria A. Jennings, Christy Ralph, Cathy Burton, Alan Melcher, Peter Hillmen, Christopher Parrish & Fiona Errington-Mais. (2023) Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells. Molecular Therapy - Oncolytics 29, pages 17-29.
Crossref
Crossref
Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord & Sigrid S. Skånland. (2023) A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine. Cell Death Discovery 9:1.
Crossref
Crossref
Donald J. Bastin, Jennifer Quizi, Michael A. Kennedy, Natasha Kekre & Rebecca C. Auer. (2022) Current challenges in the manufacture of clinical-grade autologous whole cell vaccines for hematological malignancies. Cytotherapy 24:10, pages 979-989.
Crossref
Crossref
Myriam Salazar-Terreros & Jean-Paul Vernot. (2022) In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression. International Journal of Molecular Sciences 23:13, pages 7350.
Crossref
Crossref
Paschalis Athanasiadis, Aleksandr Ianevski, Sigrid S. Skånland & Tero Aittokallio. 2022. Data Mining Techniques for the Life Sciences. Data Mining Techniques for the Life Sciences
327
348
.
Kallesh D. Jayappa, Vicki L. GordonChristopher G. MorrisBriana Wilson, B. Dharmaveer Shetty, Konrad J. Cios, Puja C. Arora, Krista M. Isaac, Shekhar Saha, Timothy P. Bender, Michael E. Williams, Craig A. Portell & Michael J. Weber. (2021) Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL. Blood Advances 5:17, pages 3497-3510.
Crossref
Crossref
Masa Lasica & Mary Ann Anderson. (2021) Review of Venetoclax in CLL, AML and Multiple Myeloma. Journal of Personalized Medicine 11:6, pages 463.
Crossref
Crossref
Hana Svozilová, Zdeněk Plichta, Vladimír Proks, Radana Studená, Jiří Baloun, Michael Doubek, Šárka Pospíšilová & Daniel Horák. (2021) RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model. International Journal of Molecular Sciences 22:5, pages 2376.
Crossref
Crossref
Sigrid S. Skånland & Anthony R. Mato. (2021) Overcoming resistance to targeted therapies in chronic lymphocytic leukemia. Blood Advances 5:1, pages 334-343.
Crossref
Crossref
Marco V. Haselager, Arnon P. Kater & Eric Eldering. (2020) Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?. Frontiers in Oncology 10.
Crossref
Crossref
Kost, Saleh, Mejia, Mostafizar, Bouchard, Banerji, Marshall, Gibson, Johnston & Katyal. (2019) Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia. Cancers 11:10, pages 1519.
Crossref
Crossref
M. Hojjat-Farsangi, A. H. Daneshmanesh, A. S. Khan, J. Shetye, F. Mozaffari, P. Kharaziha, L.-S. Rathje, P. Kokhaei, L. Hansson, J. Vågberg, S. Byström, E. Olsson, C. Löfberg, C. Norström, J. Schultz, M. Norin, T. Olin, A. Österborg, H. Mellstedt & A. Moshfegh. (2018) First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells. Leukemia 32:10, pages 2291-2295.
Crossref
Crossref
Kyle Crassini, Yandong Shen, William S. Stevenson, Richard Christopherson, Chris Ward, Stephen P. Mulligan & O. Giles Best. (2018) MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment. British Journal of Haematology 182:3, pages 360-372.
Crossref
Crossref
Yiqing Cai, Lili Feng & Xin Wang. (2018) Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia. Critical Reviews in Oncology/Hematology 126, pages 24-31.
Crossref
Crossref